"BRI is on the frontlines of human immune system research and innovation and these recent awards reflect our diverse, rich expertise and collaborative approach,” said BRI President Jane Buckner, MD. BRI received more than $17.1 million dollars in NIH-funded grants to study viral infections in vulnerable populations, type 1 diabetes, Crohn’s disease and more. Read more: https://bit.ly/3y2z3Dn GeekWire Puget Sound Business Journal #research #innovation #collaboration
About us
Benaroya Research Institute (BRI) is powering discoveries in order to learn how to rebalance the immune system in all autoimmune and immune system diseases. Our ultimate goal is to achieve a healthy immune system for each individual. Affiliated with Virginia Mason Franciscan Health. As a world-renowned, non-profit research institute we advance science that will predict, prevent, reverse and cure diseases of the immune system. Our Centers for Discovery accelerate progress through laboratory breakthroughs in immunology that can be translated to clinical therapies.
- Website
-
http://www.benaroyaresearch.org
External link for Benaroya Research Institute
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Seattle, WA
- Type
- Nonprofit
- Founded
- 1956
- Specialties
- autoimmune system, type 1 diabetes, rheumatoid arthritis, lupus, covid-19, clinical research, basic science, immune system research, and immune mediated diseases
Locations
-
Primary
1201 Ninth Avenue
Seattle, WA 98101, US
Employees at Benaroya Research Institute
Updates
-
Each year, the Federation of Clinical Immunology Societies (FOCIS) honors outstanding scientists at their annual meeting, an event where leading immunology researchers come together to pursue breakthroughs in disease therapy, share knowledge, and identify treatment commonalities to help those affected by immune system diseases. We proudly congratulate five of our scientists — Hai Nguyen, PhD, John Ray, PhD, Ritika Tewari, PhD, Soo Jung Yang, PhD, and Aisha Callebaut, PhD — who have been named as 2024 FOCIS Award recipients: bit.ly/3zN4lRK
-
-
We're #hiring a new Grants & Contracts Specialist in Seattle, Washington. Apply today or share this post with your network.
-
BRI is pleased to welcome Allyson Byrd, PhD, to our faculty as an assistant member in our Center for Systems Immunology and as the principal investigator of the Byrd Lab. An accomplished scientist, Dr. Byrd brings a wealth of experience and expertise in microbiome research, bioinformatics, and cancer immunology to our institute: bit.ly/3Sd6X1s #Microbiome #Bioinformatics #Cancer #Immunology #Research
-
-
In a study published earlier this month in Science Magazine Translational Medicine, a research team led by BRI’s Hayley Waterman, PhD, and Jessica Hamerman, PhD, describes new findings surrounding IgA autoantibodies that may lead to improved diagnosis and treatment of systemic lupus erythematosus (SLE): bit.ly/3zEFWxE Additional BRI coauthors on the publication include Matthew Dufort, PhD, Sylvia Posso, MSE, Minjian Ni, PhD, Lucy Li, MS, and Jane Buckner, MD. #AutoimmuneDisease #Lupus #Immunology #Research
-
-
We're #hiring a new Research Technician I in Seattle, Washington. Apply today or share this post with your network.
-
We're #hiring a new Postdoctoral Research Associate in Seattle, Washington. Apply today or share this post with your network.
-
We're #hiring a new Clinical Research Coordinator I in Seattle, Washington. Apply today or share this post with your network.
-
We're #hiring a new Postdoctoral Research Associate in Seattle, Washington. Apply today or share this post with your network.
-
Benaroya Research Institute reposted this
Benaroya Research Institute scientists led by Drs. Hayley Waterman and Jessica Hamerman demonstrate that IgA autoantibodies play a significant role in systemic #lupus erythematosus development. Read in Science Translational Medicine: https://bit.ly/3LfAHar Press release: https://bit.ly/4cz12vQ
-